The use of recombinant human epidermal growth factor (rhEGF) in a gentleman with drug-induced Steven Johnson syndrome

Dermatology Online Journal

Volumn 10, Issue 1, 2004, Pages

  Tsang, Man Wo ^a   Tsang, Ka Yan ^a   Wong, Wan Keung R ^b  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROXYPROPYLMETHYLCELLULOSE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT EPIDERMAL GROWTH FACTOR; SOLCOSERYL;

AGED; ARTICLE; CASE REPORT; CONJUNCTIVAL HYPEREMIA; HUMAN; INTERMETHOD COMPARISON; MALE; STEVENS JOHNSON SYNDROME;

EID: 6044269341     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wong, WKR, Lam, E, Huang, RC, Wong, RSC, Morris, C, Hackett, J. Applications, and efficient large-scale production, of recombinant human epidermal growth factor. Biotechnology and Genetic Bioengineering Reviews 2001;18:51-71.
2. Sivakesava, S., Xu, Z.N., Chen, Y.H., Hackett, J., Huang, R.C., Lam,E., Lam, T.L., Siu, K.L., Wong, R.S.C. and Wong, W.K.R. Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system. Process Biochemistry 1999;34,893-900.
3. Huang, R.C., Lam, E., Chen, Y.H., Hackett, J., Lam, T.L., Liu, D., Ma,M.C., Siu, K.L., Sivakesava, S., Xu, Z.N., Wong, R.S.C. and Wong, W.K.R. Human epidermal growth factor excreted by recombinant Escherichiacoli K-12 has the correct N-terminus and is fully bioactive. ProcessBiochemistry 1999;35:1-5.
4. Roujeau JC, Kelly JP, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
5. Guitart J. Immunopathology of Steven-Johnson syndrome. Allegy Proc. 1995;16:163-4.
6. Halebian PH, Madden MR, et al. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986;204:503-12.
7. Noskin GA, Patterson R. Outpatient management of Stevens-Johnson syndrome: A report of four cases and management strategy. Allergy Asthma Proc 1997;18:29-32.
8. Berlange Jorge Berlanga, Evelio Moreira, Luis C Perez, Eduardo Boix, Tania Gonzalez and Pedro Lopez-Saura Wound healing promotion in rats treated with egf is dose dependent. Biotecnologia Aplicada 1996 Volume 13 No. 3, pp.181-185.
9. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, Harmon JW. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995;59:236-44.
10. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, Kam G, Leung L, Chan CW, Chu CM, Lam EK. Diabetes care 2003;26:1856-1861.